tetradecanoylphorbol acetate has been researched along with Exanthema in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Britschgi, M; Keller, M; Moser, B; Pichler, WJ; Schaerli, P; Steiner, UC; Steinmann, LS | 1 |
Baghian, A; Day, RD; Jacobson, LP; Jenkins, FJ; Kingsley, LA; Kousoulas, KG; Meng, YX; Pellet, PE; Pellett, PE; Rinaldo, CR; Wang, QJ; Zhang, ZW | 1 |
2 other study(ies) available for tetradecanoylphorbol acetate and Exanthema
Article | Year |
---|---|
Characterization of human T cells that regulate neutrophilic skin inflammation.
Topics: Acute Disease; Animals; B-Lymphocytes; CD4-Positive T-Lymphocytes; Cell Survival; Cells, Cultured; Chemokines, CXC; Chemotaxis, Leukocyte; Culture Media, Conditioned; CX3C Chemokine Receptor 1; Drug Eruptions; Exanthema; Humans; Intercellular Signaling Peptides and Proteins; Interferon-gamma; Interleukin-4; Ionomycin; Membrane Proteins; Mice; Neutrophils; Receptors, Chemokine; Receptors, CXCR; Receptors, CXCR4; Receptors, G-Protein-Coupled; Receptors, Interleukin-8A; Receptors, Interleukin-8B; Skin; Skin Diseases, Vesiculobullous; T-Lymphocyte Subsets; Tetradecanoylphorbol Acetate; Transfection; Tumor Necrosis Factor-alpha | 2004 |
Primary human herpesvirus 8 infection generates a broadly specific CD8(+) T-cell response to viral lytic cycle proteins.
Topics: Adult; Amino Acid Sequence; Antibodies, Viral; Antigens, Viral; Capsid; DNA, Viral; Exanthema; Fatigue; Glycoproteins; Herpesviridae Infections; Herpesvirus 8, Human; HIV Seronegativity; Homosexuality; Humans; Immunologic Memory; Immunophenotyping; Incidence; Interferon-gamma; Ionomycin; Longitudinal Studies; Lymphatic Diseases; Lymphocyte Activation; Lymphocyte Count; Male; Middle Aged; Mitogens; Molecular Sequence Data; Phosphoproteins; Prospective Studies; T-Lymphocyte Subsets; Tetradecanoylphorbol Acetate; Viral Envelope Proteins; Viral Matrix Proteins; Viral Proteins; Viremia | 2001 |